MedPath
NMPA Approval

Bortezomib for Injection

国药准字H20253217

January 14, 2025

Drug Information

注射用硼替佐米

注射剂

3.5mg

化学药品

January 14, 2025

Company Information

Applicant Company

山西省大同经济技术开发区第一医药园区

Manufacturing Company

山西省大同经济技术开发区第一医药园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用硼替佐米 - NMPA 批准文号 | MedPath